Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 18.41
(-1.13%)
CNY 18.41
(-1.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 639.22 Million CNY | 27.27% |
| 2022 | 502.25 Million CNY | 76.67% |
| 2021 | 284.28 Million CNY | 16.32% |
| 2020 | 244.39 Million CNY | -31.35% |
| 2019 | 356.02 Million CNY | 43.97% |
| 2018 | 247.29 Million CNY | 42.38% |
| 2017 | 173.68 Million CNY | 66.61% |
| 2016 | 104.24 Million CNY | 13.51% |
| 2015 | 91.84 Million CNY | -3.14% |
| 2014 | 94.82 Million CNY | 30.28% |
| 2013 | 72.78 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 461.81 Million CNY | 29.96% |
| 2024 Q1 | 355.35 Million CNY | -44.41% |
| 2024 Q3 | 471 Million CNY | 1.99% |
| 2023 Q1 | 579.45 Million CNY | 15.37% |
| 2023 FY | 639.22 Million CNY | 27.27% |
| 2023 Q4 | 639.22 Million CNY | 6.57% |
| 2023 Q2 | 550.03 Million CNY | -5.08% |
| 2023 Q3 | 599.83 Million CNY | 9.05% |
| 2022 Q4 | 502.25 Million CNY | 42.18% |
| 2022 FY | 502.25 Million CNY | 76.67% |
| 2022 Q3 | 353.24 Million CNY | 26.12% |
| 2022 Q1 | 275.45 Million CNY | -3.1% |
| 2022 Q2 | 280.08 Million CNY | 1.68% |
| 2021 Q3 | 281.38 Million CNY | 14.27% |
| 2021 FY | 284.28 Million CNY | 16.32% |
| 2021 Q4 | 284.28 Million CNY | 1.03% |
| 2021 Q2 | 246.25 Million CNY | 18.44% |
| 2021 Q1 | 207.92 Million CNY | -14.92% |
| 2020 FY | 244.39 Million CNY | -31.35% |
| 2020 Q4 | 244.39 Million CNY | -37.7% |
| 2020 Q2 | 391.99 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q3 | 392.29 Million CNY | 0.08% |
| 2019 Q4 | 356.02 Million CNY | 0.0% |
| 2019 FY | 356.02 Million CNY | 43.97% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 247.29 Million CNY | 42.38% |
| 2017 FY | 173.68 Million CNY | 66.61% |
| 2016 FY | 104.24 Million CNY | 13.51% |
| 2015 FY | 91.84 Million CNY | -3.14% |
| 2014 FY | 94.82 Million CNY | 30.28% |
| 2013 FY | 72.78 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Lifecome Biochemistry Co.,Ltd. | 1.55 Billion CNY | 58.783% |
| Chengdu Kanghua Biological Products Co., Ltd. | 689.01 Million CNY | 7.226% |
| NanHua Bio-medicine Co., Ltd | 466.7 Million CNY | -36.965% |
| Shandong Sito Bio-technology Co., Ltd. | 1.17 Billion CNY | 45.588% |
| Porton Pharma Solutions Ltd. | 3.17 Billion CNY | 79.861% |
| Guangdong VTR Bio-Tech Co., Ltd. | 359.78 Million CNY | -77.669% |